Celyad Announces June 2020 Conference Schedule

Celyad Announces June 2020 Conference Schedule

Celyad Announces First Quarter 2020 Financial Results and Recent Business Highlights

Celyad Announces First Quarter 2020 Financial Results and Recent Business Highlights

Celyad Appoints Seasoned Industry Executives to Board of Directors

Celyad Appoints Seasoned Industry Executives to Board of Directors

Celyad to Present Update from CYAD-101 for Advanced Colorectal Cancer and Next-Generation shRNA Platform at 2020 ASCO Virtual Scientific Program

Celyad to Present Update from CYAD-101 for Advanced Colorectal Cancer and Next-Generation shRNA Platform at 2020 ASCO Virtual Scientific Program

Celyad to Host Remote 2020 Ordinary General Meeting

Celyad to Host Remote 2020 Ordinary General Meeting

Celyad Reports Full Year 2019 Financial Results and Provides Business Update

Celyad Reports Full Year 2019 Financial Results and Provides Business Update

Celyad to Announce Full Year 2019 Financial Results and Host Conference Call

Celyad to Announce Full Year 2019 Financial Results and Host Conference Call

Celyad Appoints Stephen Rubino as Chief Business Officer

Celyad Appoints Stephen Rubino as Chief Business Officer

Celyad Announces February and March 2020 Conference Schedule

Celyad Announces February and March 2020 Conference Schedule

Letter to Shareholders - January 2020

Letter to Shareholders - January 2020

Celyad Successfully Doses First Patient with CYAD-02 in CYCLE-1 Trial for r/r AML and MDS

Celyad Successfully Doses First Patient with CYAD-02 in CYCLE-1 Trial for r/r AML and MDS

Celyad Presents Update on r/r AML and MDS Program at 61st ASH Annual Meeting

Celyad Presents Update on r/r AML and MDS Program at 61st ASH Annual Meeting